高级检索
王福兴, 卢德威, 范文海, 王亚芹, 何联祥, 樊桂风, 那国富, 葛莲江, 何长文. 肾综合征出血热Ⅰ型灭活疫苗安全性、免疫效果和免疫增强研究[J]. 中国公共卫生, 1999, 15(7): 610-611.
引用本文: 王福兴, 卢德威, 范文海, 王亚芹, 何联祥, 樊桂风, 那国富, 葛莲江, 何长文. 肾综合征出血热Ⅰ型灭活疫苗安全性、免疫效果和免疫增强研究[J]. 中国公共卫生, 1999, 15(7): 610-611.
Wang FuXing, Lu Dewei, . Evaluation on the Safety and Immunological Effect and Enhancement of Type I Inactivated Vaccine against Hemorrhagic Fever with Renal Syndrome[J]. Chinese Journal of Public Health, 1999, 15(7): 610-611.
Citation: Wang FuXing, Lu Dewei, . Evaluation on the Safety and Immunological Effect and Enhancement of Type I Inactivated Vaccine against Hemorrhagic Fever with Renal Syndrome[J]. Chinese Journal of Public Health, 1999, 15(7): 610-611.

肾综合征出血热Ⅰ型灭活疫苗安全性、免疫效果和免疫增强研究

Evaluation on the Safety and Immunological Effect and Enhancement of Type I Inactivated Vaccine against Hemorrhagic Fever with Renal Syndrome

  • 摘要: 以接种反应程度观察疫苗的安全性;以血清抗体连续检测观察疫苗的血清学效果;以现场保护率观察疫苗的流行病学效果;以对比法观察疫苗免疫(感染)增强。结果表明疫苗接种反应率0.89%,其中中强反应率0.03%;疫苗基础免疫完成后2周?加强前?加强后2周?加强后1年?加强后2年,血清中和抗体阳转率分别为70.00%?50.00%?91.18%?58.97%和38.89%,荧光抗体阳转率分别为83.33%?12.90%?64.52%?41.03%和13.89%;1995年10月至1998年9月,试区接种人群疫苗保护率94.99%;目前尚未发现接种人群有免疫(感染)增强问题。表明杭州天元生物药业公司生产的HFRS沙鼠肾细胞Ⅰ型灭活疫苗具有较好的安全性和近期(3年)防病效果。

     

    Abstract: Objective:The purpose of this report was to observe the safety.serological efficacy,epidemiological efficacy and antibody dependent immunization enhancement of inactivated vaccine against HFRS(Type 1)form tissue culture of Mongolian gerbils Kindney.Methods:Observe the safety by the reaction f the vaccine;Observe the serological efficacy by Immuno fluorescent antibody assay used in testing specific IgG antibody and Mcro-CPE method was used in testing the titer of neutralizing antibody;Observethe the epidemiological eficacy by the protection rates.Results:The reaction of the vaccine was slight The moderate and severe side effects was 0.03%;14 days after three doses of injection before reinforced 14 days and 1 year and 2 year after reinforced? The rates of seroconversion of neutralizing antibody by the Mcro-CPE method were70.00%,50 00%,91 18%,58 97% and 38.89%;The rates of seroconversion of immuno fluorescent antibodyby IFA method were 83.33%,12.90%,64.52%,4103% and 13.89%;After epidemic season s observation this kind of vaccine was effective and the protection rate was 94.99%;Til now.we haven't find any antibody dependent immunization enhancement phenomenon among the inoculated population Conclusion:This kind of vaccine by Hangzhou Tianyuan Biol was all epidemiologically effective.

     

/

返回文章
返回